Informatica logs earnings beat, following acquisition flirtation with Salesforce
By Jon Swartz
Annual recurring revenue increased 13%
Informatica Inc. beat expectations with its latest quarterly results Wednesday, but its stock barely budged in after-hours trading.
"What we have built is the AI-powered data-management platform for mission-critical operational workloads for enterprises," Chief Executive Amit Walia said in an interview. He said that annual recurring revenue increased 13% year over year to $1.16 billion.
Informatica (INFA) posted first-quarter net income of $9.3 million, or 3 cents a share, compared with a net loss of $116.4 million, or 41 cents a share, in the same quarter a year ago. Adjusted earnings were 22 cents a share.
Total revenue was $388.6 million, up slightly from $365.4 million in the year-ago quarter.
Analysts surveyed by FactSet had expected, on average, adjusted earnings of 20 cents a share on revenue of $388 million.
Shares ended the extended session up 0.03%.
Informatica, which has been linked to a potential acquisition by Salesforce Inc. (CRM) that fell through, provided second-quarter sales guidance of $394 million to $410 million. FactSet analysts are forecasting $401 million.
Walia declined to address a potential deal, instead emphasizing larger economic factors.
"So much this quarter has been focused on macro events like the [Federal Reserve] and [the consumer-price index]," Walia said. "It has superseded everything else."
Shares of Informatica, which operates a cloud platform for data management, have improved 8.7% this year through Wednesday, while the broader S&P 500 SPX has advanced 5%.
-Jon Swartz
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-01-24 2021ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks